Extendicare Inc (EXE)

Currency in CAD
33.92
+0.36(+1.07%)
Closed·
EXE is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
33.5034.48
52 wk Range
12.1235.62
Key Statistics
Bid/Ask
33.82 / 34.00
Prev. Close
33.56
Open
33.62
Day's Range
33.5-34.48
52 wk Range
12.12-35.62
Volume
317.28K
Average Volume (3m)
342.75K
1-Year Change
137.037%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EXE Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
37.61
Upside
+10.88%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a low P/E ratio relative to near-term earnings growth

Extendicare Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy

Analyst Ratings

9 Buy
0 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 37.61
(+10.88% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BMO Capital
Buy38.00+12.03%30.00Maintain13/05/2026
Desjardins
Buy34.50+1.71%-New Coverage22/04/2026
RBC Capital
Buy30.00-11.56%25.00Maintain03/03/2026
BMO Capital
Buy30.00-11.56%24.00Maintain02/03/2026
RBC Capital
Buy25.00-26.30%15.00Upgrade04/12/2025

Extendicare Inc Earnings Call Summary for Q1/2026

  • Q1 2026 EPS of CAD 0.422 beat estimates by 107.58%; shares surged 10.84% to CAD 33.44 in after-hours trading despite revenue miss.
  • Revenue rose 24.2% YoY to CAD 465.2M; Home Healthcare volume jumped 32.7% via acquisitions and organic growth; AFFO up 65% to CAD 32.7M.
  • Completed transformational CBI Home Health acquisition, expanding Western Canada presence and service capacity significantly.
  • FY2026 guidance: EPS of CAD 8.99, revenue CAD 9.8B; FY2027: EPS CAD 9.3, revenue CAD 9.98B, driven by Home Healthcare expansion.
  • Key risks include labor shortages in allied health, supply chain disruptions, market saturation, and potential regulatory changes in healthcare funding.
Last Updated: 14/05/2026, 18:52
Read Full Transcript

Earnings

Latest Release
07/05/2026
EPS / Forecast
0.42 / 0.20
Revenue / Forecast
465.22M / 508.15M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.37%
Dividend Yield
1.56%
Industry Median 2.40%
Annualised payout
0.53
Paid monthly
5-Years Growth
+1.06%
Growth Streak

Compare EXE to Peers and Sector

Metrics to compare
EXE
Peers
Sector
Relationship
P/E Ratio
26.0x6.8x−0.5x
PEG Ratio
0.490.060.00
Price/Book
8.1x1.0x2.6x
Price / LTM Sales
1.8x0.6x3.1x
Upside (Analyst Target)
10.8%31.2%53.0%
Fair Value Upside
Unlock−2.9%6.3%Unlock

Extendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. It operates through the Long-term Care, Home Health Care, and Managed Services segments. The company offers long-term care services, such as accommodation and meals, and assistance with activities of daily living and continuing care to residents; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties and joint ventures. It provides its services under the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Network brands. The company was incorporated in 1968 and is based in Markham, Canada.

Employees
23500
Market
Canada

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
16.95M17.94%568.82M
Other Institutional Investors
20.08M21.25%673.74M
Public Companies & Retail Investors
57.43M60.80%1.93B
Total
94.46M100.00%3.17B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Global Alpha Capital Management Ltd.8.80%8,310,855278,912
Sandpiper Asset Management, Inc8.73%8,242,816276,629

People Also Watch

89.98
CCLb
+0.36%
73.96
SJ
+1.58%
96.46
WN
-0.38%
16.85
CHE_u
+0.72%
105.75
STN
+0.84%

FAQ

What Is the Extendicare Inc (Toronto: EXE) Share Price Today?

The Extendicare Inc stock price today is 33.92 CAD.

What Stock Exchange Does Extendicare Inc (EXE) Trade On?

Extendicare Inc is listed and trades on the Toronto Stock Exchange.

What Is the Ticker (Stock Symbol) for Extendicare Inc?

The stock symbol (also called a 'ticker') for Extendicare Inc is "EXE."

Does Extendicare Inc Pay Dividends? What’s The Current EXE Dividend Yield?

Yes, EXE Pays Dividends to its Shareholders. The current Extendicare Inc dividend yield is 1.58%.

What Is the Current Extendicare Inc Market Capitalisation?

As of today, Extendicare Inc (Toronto: EXE) market cap is 3.22B CAD.

What Is Extendicare Inc's (EXE) Earnings Per Share (TTM)?

The Extendicare Inc EPS is currently 1.37 (Trailing Twelve Months).

When Is the Next Extendicare Inc Earnings Date?

Extendicare Inc's next earnings report will be released on 12/08/2026.

Is EXE a Buy or Sell From a Technical Analyst Perspective?

Based on today's Extendicare Inc moving averages and other technical indicators, the daily buy/sell signal for EXE stock is Strong Buy.

How Many Times Has Extendicare Inc Stock Split?

Extendicare Inc has split 0 times. (See the EXE stock split history page for full effective split date and price information.)

How Many Employees Does Extendicare Inc Have?

Extendicare Inc has 23500 employees, based on their latest Companies House report.

What is the current trading status of Extendicare Inc (Toronto: EXE)?

As of 23/05/2026, Extendicare Inc (EXE) is trading at a share price of 33.92 CAD, with a previous close of 33.56 CAD. The stock has fluctuated within a day range of 33.50 CAD to 34.48 CAD, while its 52-week range spans from 12.12 CAD to 35.62 CAD.

What Is Extendicare Inc (EXE) Price Target According to Analysts?

The average 12-month price target for Extendicare Inc is 37.61 CAD, with a high estimate of 43 CAD and a low estimate of 31.5 CAD. 9 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +10.88% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.